Hyperimmune Colostrum and Oral Mucositis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00699569
First received: June 17, 2008
Last updated: July 22, 2008
Last verified: June 2008

June 17, 2008
July 22, 2008
July 2008
July 2009   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00699569 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Hyperimmune Colostrum and Oral Mucositis
The Effect of Hyperimmune Colostrum on Radiation-Induce Oral Mucositis of Patients With Head and Neck Cancer

To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Supportive Care
Head and Neck Cancer
  • Dietary Supplement: hyperimmune colostrum
    hyperimmune colostrum
  • Dietary Supplement: Placebo
  • Experimental: 1
    Patients receiving active investigational product
    Intervention: Dietary Supplement: hyperimmune colostrum
  • Placebo Comparator: 2
    Patients receiving Placebo
    Intervention: Dietary Supplement: Placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
30
July 2009
July 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer.

Exclusion Criteria:

  • Other tumors
  • Non-epithelial tumors
  • Pregnancy
  • Poor functional status
Both
18 Years and older
No
Contact: Nachum Vaisman, Prof' 972-3-697-4807 vaisman@tasmc.health.gov.il
Israel
 
NCT00699569
TASMC-08-NV-248, 0248-08-TLV
No
Nachum Vaisman Prof', Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center
Not Provided
Principal Investigator: Nachum Vaisman, Prof' Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center
June 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP